Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease (Q28186326)

12 December 2020

X-linked chronic granulomatous disease: more than two years later.

1 reference

12 December 2020

Altered expression of neutrophil peripheral benzodiazepine receptor in X-linked chronic granulomatous disease

1 reference

12 December 2020

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

1 reference

12 December 2020

New perspectives in chronic granulomatous disease

1 reference

12 December 2020

Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils.

1 reference

12 December 2020

Reconstitution of peripheral benzodiazepine receptor expression in X-linked chronic granulomatous disease by interferon-gamma

1 reference

12 December 2020

Reevaluation of cytochrome b and flavin adenine dinucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with probable autosomal recessive inheritance of cytochrome b deficiency

1 reference

12 December 2020

Classification of chronic granulomatous disease

1 reference

12 December 2020

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

12 December 2020

Developments in the treatment of patients with chronic granulomatous disease

1 reference

12 December 2020

Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell.

1 reference

12 December 2020

Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease

1 reference

12 December 2020

Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans

1 reference

12 December 2020

The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease

1 reference

12 December 2020

Interferon-gamma: a review

1 reference

12 December 2020

Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease

1 reference

12 December 2020

Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma

1 reference

12 December 2020

Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance

1 reference

12 December 2020

Molecular genetics of chronic granulomatous disease

1 reference

12 December 2020

In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.

1 reference

12 December 2020

Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages

1 reference

12 December 2020

Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease

1 reference

12 December 2020

Gamma-interferon: physiology and speculation on its role in medicine

1 reference

12 December 2020

Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii

1 reference

12 December 2020

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine

1 reference

12 December 2020

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood

1 reference

12 December 2020

Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

1 reference

12 December 2020

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

12 December 2020

Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1

1 reference

12 December 2020

Interferon-gamma: mechanism of action and therapeutic potential

1 reference

12 December 2020

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

12 December 2020

Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors.

1 reference

12 December 2020

Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy

1 reference

12 December 2020

NIH conference. Recent advances in chronic granulomatous disease

1 reference

12 December 2020

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide

1 reference

12 December 2020

Nocardia pneumonia in a neonate with chronic granulomatous disease

1 reference

12 December 2020

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

12 December 2020

Interferon gamma: a master key in the immune system

1 reference

12 December 2020

Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages

1 reference

12 December 2020